Côte d'Ivoire vs Niger: Protecting minority investors: Strength of minority investor
Côte d'Ivoire
21 DB15-20 methodology
in 2019
Niger
21 DB15-20 methodology
in 2019
Côte d'Ivoire rank
120th
Niger rank
120th
Protecting minority investors: Strength of minority investor over time
- Côte d'Ivoire
- Niger
How they compare
Côte d'Ivoire currently reports 21 DB15-20 methodology against 21 DB15-20 methodology in Niger, a difference of 0 DB15-20 methodology.
The two have swapped places 1 time across 7 shared years of data; in 2013 it was Côte d'Ivoire ahead.
Côte d'Ivoire ranks 120th and Niger ranks 120th of 191 countries.
Côte d'Ivoire has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher protecting minority investors: strength of minority investor, Côte d'Ivoire or Niger?
- Côte d'Ivoire, at 21 DB15-20 methodology against 21 DB15-20 methodology in Niger as of 2019.
- What is the difference in protecting minority investors: strength of minority investor between Côte d'Ivoire and Niger?
- 0 DB15-20 methodology, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Niger?
- 7 years are reported by both, from 2013 to 2019.
- How do Côte d'Ivoire and Niger rank globally for protecting minority investors: strength of minority investor?
- Côte d'Ivoire ranks 120th and Niger ranks 120th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Strength of minority investor protection index (0-50) (DB15-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The strength of minority investor protection index is the sum of the extent of disclosure index, extent of director liability index, ease of shareholder suits index, extent of shareholder rights index, extent of ownership and control index and extent of corporate transparency index. The index is computed based on the methodology in the DB15-20 studies.